Breast, Prostate Imaging Regimens Would Be Aided By GEMS/Genometrix
This article was originally published in The Gray Sheet
Executive Summary
GE Medical Systems will combine its molecular diagnostic imaging platform with Genometrix' microarray gene and protein analysis technology to develop biomarkers for breast and prostate cancer.